Search research articles
Contact Us
Filters
Showing results (1-10 of 191) with videos related to
Page
of 20
Sort By:
Tumori
|
April 21, 2016
Application of OECI accreditation program to cancer institutes of the Alleanza Contro il Cancro Italian Network: a special project supported by the Italian Ministry of Health
Angelo Paradiso, Filippo Belardelli
Applied & Translational Genomics
|
June 9, 2016
Rare disease research: Breaking the privacy barrier
Deborah Mascalzoni, Angelo Paradiso, Matts Hansson
International Journal of Oncology
|
November 8, 2005
Telomeres, telomerase and oral cancer (Review)
Sinto Sebastian, Luciano Grammatica, Angelo Paradiso
Current Genomics
|
November 2, 2013
Mitochondria and familial predisposition to breast cancer
Stefania Weigl, Angelo Paradiso, Stefania Tommasi
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
May 30, 2009
HCC heterogeneity: molecular pathogenesis and clinical implications
Emilia Fransvea, Angelo Paradiso, Salvatore Antonaci, et al.
Cancer Genomics & Proteomics
|
June 25, 2020
Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model
Rosa Divella, Antonella Daniele, Eufemia Savino, et al.
International Journal of Environmental Research and Public Health
|
April 23, 2020
COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori "Giovanni Paolo II" of Bari
Nicola Silvestris, Antonio Moschetta, Angelo Paradiso, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2003
The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines
Jian-Ming Xu, Amalia Azzariti, Giuseppe Colucci, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
July 21, 2007
BRAF in papillary thyroid carcinoma
Salvatore Giovanni Lanzilotta, Luciano Grammatica, Angelo Paradiso, et al.
Critical Reviews in Oncology/Hematology
|
March 11, 2011
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009)
Veronica Goffredo, Angelo Paradiso, Girolamo Ranieri, et al.
Page
of 20
Search research articles
Search
Showing results (1-10 of 191) with videos related to
Sort By:
Page
of 20
Tumori
|
April 21, 2016
Application of OECI accreditation program to cancer institutes of the Alleanza Contro il Cancro Italian Network: a special project supported by the Italian Ministry of Health
Angelo Paradiso, Filippo Belardelli
Applied & Translational Genomics
|
June 9, 2016
Rare disease research: Breaking the privacy barrier
Deborah Mascalzoni, Angelo Paradiso, Matts Hansson
International Journal of Oncology
|
November 8, 2005
Telomeres, telomerase and oral cancer (Review)
Sinto Sebastian, Luciano Grammatica, Angelo Paradiso
Current Genomics
|
November 2, 2013
Mitochondria and familial predisposition to breast cancer
Stefania Weigl, Angelo Paradiso, Stefania Tommasi
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
May 30, 2009
HCC heterogeneity: molecular pathogenesis and clinical implications
Emilia Fransvea, Angelo Paradiso, Salvatore Antonaci, et al.
Cancer Genomics & Proteomics
|
June 25, 2020
Anticancer Effects of Nutraceuticals in the Mediterranean Diet: An Epigenetic Diet Model
Rosa Divella, Antonella Daniele, Eufemia Savino, et al.
International Journal of Environmental Research and Public Health
|
April 23, 2020
COVID-19 Pandemic and the Crisis of Health Systems: The Experience of the Apulia Cancer Network and of the Comprehensive Cancer Center Istituto Tumori "Giovanni Paolo II" of Bari
Nicola Silvestris, Antonio Moschetta, Angelo Paradiso, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2003
The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines
Jian-Ming Xu, Amalia Azzariti, Giuseppe Colucci, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
July 21, 2007
BRAF in papillary thyroid carcinoma
Salvatore Giovanni Lanzilotta, Luciano Grammatica, Angelo Paradiso, et al.
Critical Reviews in Oncology/Hematology
|
March 11, 2011
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009)
Veronica Goffredo, Angelo Paradiso, Girolamo Ranieri, et al.
Page
of 20